Manufacturers Life Insurance Company, The Albireo Pharma, Inc. Transaction History

Manufacturers Life Insurance Company, The

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $137,826 - $277,213	-7,434 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$23.94 - $33.74 $177,969 - $250,823	7,434 New	7,434 $221,000
Q1 2022 May 20, 2022	SELL	$23.94 - $33.74 $55,277 - $77,905	-2,309 Reduced 23.7%	7,434 $222,000
Q4 2021 Feb 16, 2022	BUY	$21.19 - $31.29 $3,008 - $4,443	142 Added 1.48%	9,743 $227,000
Q3 2021 Nov 12, 2021	SELL	$27.36 - $35.98 $14,555 - $19,141	-532 Reduced 5.25%	9,601 $300,000

Q2 2021 Aug 12, 2021	SELL	$28.9 - $36.87 $6,936 - $8,848	-240 Reduced 2.31%	10,133 $356,000
Q1 2021 May 03, 2021	SELL	$32.03 - $42.85 $2,498 - $3,342	-78 Reduced 0.75%	10,373 $366,000
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $75,081 - $100,298	2,379 Added 29.47%	10,451 $392,000
Q3 2020 Nov 09, 2020	SELL	$23.19 - $41.61 $5,959 - $10,693	-257 Reduced 3.09%	8,072 $269,000
Q2 2020 Aug 10, 2020	BUY	$14.82 - $29.92 $123,435 - $249,203	8,329 New	8,329 $227,000
Q3 2019 Nov 12, 2019	SELL	$20.0 - $31.88 $142,500 - $227,145	-7,125 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $218,523 - $269,752	7,125 New	7,125 $230,000
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $221,783 - $279,179	-7,572 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $208,686 - $269,415	7,221 Added 2057.26%	7,572 $269,000
Q1 2018 May 15, 2018	SELL	$26.78 - $39.35 $26 - $39	-1 Reduced 0.28%	351 $11,000
Q4 2017 Feb 08, 2018	BUY	$21.56 - $28.14 $86 - $112	4 Added 1.15%	352 $9,000
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $7,113 - $8,926	348	348 $7,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.